Maze Therapeutics Inc (NASDAQ:MAZE) does about 324.29K shares in volume on a normal day but saw 1048775 shares change hands in the recent trading day. The company now has a market cap of 433.58M USD. Its current market price is $9.90, marking a decrease of -10.08% compared to the previous close of $11.01. The 52 week high reached by this stock is $17.00 whilst the lowest price level in 52 weeks is $9.88.
Maze Therapeutics Inc (MAZE) has a 20-day trading average at $11.44 and the current price is -41.76% off the 52-week high compared with 0.20% distance from its 52-week low. If we look at the stock’s price movements over the week, volatility stands at 11.02%, which increases to 11.96% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 34.68 to suggest the stock is neutral.
The consensus objective for the share price is $25.67, suggesting that the stock has a potential upside of 61.43% over the period.
The current price level is -13.47%, -17.42%, and -17.42% away from its SMA20, SMA50, and SMA200 respectively, with the MAZE price moving above the 50-day SMA on current market day. Maze Therapeutics Inc (MAZE) stock is down -14.88% over the week and -10.33% over the past month. Its price is -37.93% year-to-date.
The company’s next earnings report forecasts estimating quarterly EPS at -0.62 and -2.52 for whole year.
To reach the target analysts have set, the stock logically needs to grow 61.43 percent from here.
Outstanding shares total 43.80M with insiders holding 11.49% of the shares and institutional holders owning 56.93% of the company’s common stock.
